Ratings
0
Nobody has rated this yet. Be the first!
Works
2
The dynamic human immune response to cancer: it might just be rocket science
A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1
